MORE►
Discovery
Left: Milan Radovich, SVP and Chief Scientific Officer at Caris Life Sciences; Right: Boris L. Zaïtra, Head of Roche Corporate Business Development [Photos: LinkedIn/Roche]
North Texas’ Caris Life Sciences To Collaborate With Genentech on Novel Therapeutic Targets for Cancers
by Sandra Engelland | Dec 17, 2025
Under the terms of the agreement, Caris is eligible to receive upfront and near-term payments of $25 million and is also eligible for up to $1.1 billion of potential research, development, commercial, and net sales payments, as well as potential tiered royalties on net sales of collaboration therapies, the company said.
by Sandra Engelland |
Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE►
by Quincy Preston |
Dec 8, 2025
The federal ARPA-E award adds to the Dallas-based company’s momentum as it advances next-generation battery materials and builds out new power tech for AI data centers.
MORE►
by Maddie Preston |
Dec 8, 2025
The pilot will test Last Energy’s 5-megawatt PWR-5 design at Texas A&M–RELLIS while the company advances a plan for 30 commercial microreactors in Haskell County northwest of Dallas-Fort Worth to serve data center growth.
MORE►
[Image: Rawpixel/istockphoto]
HF Controls’ $450K Gift Backs Nuclear and AI Research at UTA
by Maddie Preston | Dec 5, 2025
The investment strengthens UTA’s pipeline for high-demand engineering talent and supports research on AI-enabled safety systems for nuclear plants.
MORE►
by Dallas Innovates | Staff Report |
Dec 5, 2025
The Cancer Prevention & Research Institute of Texas offers funding opportunities for promising cancer research, product development, and prevention programs. The state-funded initiative stands as the second-largest public backer of cancer research in the U.S. after the National Cancer Institute.
MORE►
by Lance Murray |
Dec 3, 2025
The grant is intended to accelerate a pioneering triple-negative breast cancer clinical trial that could advance early detection initiatives and shift care from reactive to proactive at the newly established Texas Cancer Interception Institute.
MORE►
by Maddie Preston |
Nov 24, 2025
The brain-inspired design could lower the energy and compute costs behind AI training requirements, an increasingly urgent challenge for enterprises.
MORE►
4KAgent from Topaz Labs and its partners. [Video still: Topaz Labs]
Dallas’ Topaz Labs Partners with Texas A&M, Stanford, CalTech, and Others on Use of Agentic AI for Photo Editing & Restoration
by Lance Murray | Oct 21, 2025
The system's open-source framework integrates more than 50 specialized AI models to autonomously analyze, plan, and restore images, "mirroring the decision-making process of a professional editor."
MORE►
by Quincy Preston |
Oct 16, 2025
Permanent crowns custom printed in all-ceramic zirconia could soon be a chair-side reality for dental patients, thanks to University of Texas at Dallas researchers. Backed by a $550,000 National Science Foundation grant, the team is working to commercialize the technology.
MORE►
by Quincy Preston |
Oct 15, 2025
Researchers at UTSW identified a set of neurons in the "brain's timekeeper" that may drive nighttime snacking—and in mice, control up to 7% of body weight. The discovery could pave the way for new weight-loss strategies.
MORE►
NIH Grants $1.84M to UTA Research Team Studying How the Immune System Can Go Wrong—and How to Fix It
by Lance Murray |
Oct 4, 2025
The research could lead to better treatments for disease, including cancer.
MORE►
From left: Charles Freeman, Leslie Browning-Samoni and Adelaide Lovett [Photo: TCU]
TCU Student Uncovers Fashion’s Hidden Costs—And Designs for the Moon
by Maddie Preston | Sep 26, 2025
In a published study, Adelaide Lovett traced how synthetic fibers shed microplastics that can end up in human organs. She also co-designed astronaut gear to guard against lunar dust—a project that earned a NASA innovation award.
MORE►
by Lance Murray |
Sep 26, 2025
In Stephenville—about 70 miles southwest of Fort Worth—the new facility adds labs, research space, and clinical classrooms as part of a broader push to expand rural healthcare education across Texas.
MORE►
by Lance Murray |
Sep 18, 2025
UT Southwestern in Dallas will lead three liver cancer projects on prevention, recurrence, and immunotherapy. It joins Mayo Clinic and MD Anderson as a national NCI SPORE site, a program that moves discoveries into clinical trials.
MORE►
by Lance Murray |
Sep 11, 2025
The discovery reveals why people may be more susceptible to infections at certain times of day—and could open new paths for cancer immunotherapy and infection treatments.
MORE►
